Eli Lilly and Company
POLYMORPHS OF AN FXR AGONIST

Abstract:

Provided herein are polymorphs of 6-(4-((5-cyclopropyl-3-(2,6-dichlorophenyl)isoxazol-4-yl)methoxy)piperidi- n-1-yl)-1-methyl-1H-indole-3-carboxylic acid, compositions thereof, methods of preparation thereof, and methods of use thereof.